Broderick Brian C Grows Position in Procter & Gamble Company (The) $PG

Broderick Brian C grew its holdings in shares of Procter & Gamble Company (The) (NYSE:PGFree Report) by 4.7% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 103,347 shares of the company’s stock after acquiring an additional 4,625 shares during the quarter. Procter & Gamble comprises 2.8% of Broderick Brian C’s investment portfolio, making the stock its 12th largest position. Broderick Brian C’s holdings in Procter & Gamble were worth $14,927,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the stock. Norges Bank bought a new stake in Procter & Gamble during the fourth quarter valued at approximately $4,664,783,000. Cardano Risk Management B.V. grew its stake in Procter & Gamble by 1,104.8% in the 4th quarter. Cardano Risk Management B.V. now owns 9,521,440 shares of the company’s stock worth $1,364,518,000 after buying an additional 8,731,126 shares in the last quarter. Auto Owners Insurance Co increased its holdings in shares of Procter & Gamble by 14,231.0% in the 4th quarter. Auto Owners Insurance Co now owns 3,549,645 shares of the company’s stock worth $508,700,000 after buying an additional 3,524,876 shares during the last quarter. Vanguard Group Inc. raised its position in shares of Procter & Gamble by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 237,459,756 shares of the company’s stock valued at $34,030,358,000 after buying an additional 2,829,151 shares in the last quarter. Finally, Assenagon Asset Management S.A. raised its position in shares of Procter & Gamble by 100.8% during the 4th quarter. Assenagon Asset Management S.A. now owns 5,460,939 shares of the company’s stock valued at $782,607,000 after buying an additional 2,741,924 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Trading Down 0.1%

Shares of PG opened at $149.84 on Monday. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The firm has a market cap of $348.92 billion, a price-to-earnings ratio of 21.91, a PEG ratio of 7.46 and a beta of 0.39. The firm has a 50 day moving average price of $146.80 and a 200-day moving average price of $148.56. The company has a debt-to-equity ratio of 0.44, a quick ratio of 0.53 and a current ratio of 0.73.

Procter & Gamble (NYSE:PGGet Free Report) last released its earnings results on Friday, April 24th. The company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.56 by $0.03. The company had revenue of $21.23 billion for the quarter, compared to analyst estimates of $21.52 billion. Procter & Gamble had a net margin of 19.16% and a return on equity of 32.00%. The firm’s quarterly revenue was up 7.4% compared to the same quarter last year. During the same quarter last year, the firm earned $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities research analysts forecast that Procter & Gamble Company will post 6.88 earnings per share for the current year.

Procter & Gamble Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Monday, August 17th. Stockholders of record on Friday, July 24th will be paid a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.9%. The ex-dividend date of this dividend is Friday, July 24th. Procter & Gamble’s dividend payout ratio (DPR) is 63.60%.

Procter & Gamble News Summary

Here are the key news stories impacting Procter & Gamble this week:

  • Positive Sentiment: Procter & Gamble’s long dividend track record remains a key support for the stock, with the company having raised its payout for 70 consecutive years, reinforcing its status as a dependable income name. Article title
  • Positive Sentiment: JPMorgan kept an overweight rating on PG while only trimming its price target to $162 from $164, signaling continued upside expectations from current levels. Article title
  • Positive Sentiment: Some commentary says PG still screens as undervalued and could benefit from planned cuts to as many as 7,000 non-manufacturing roles, which may improve margins over time. Article title
  • Neutral Sentiment: Erste Group slightly lowered its FY2026 and FY2027 earnings estimates, but the changes were minimal and its full-year FY2026 forecast still matches consensus. Article title
  • Neutral Sentiment: UBS said consumer-staple companies likely had another “tricky” quarter, which suggests a challenging operating backdrop for PG and peers rather than a company-specific setback. Article title
  • Negative Sentiment: The stock is also being pressured by a broader risk-off move and weakness in equities, including a selloff in growth/AI-related names that has pushed some investors back toward defensive stocks like PG. Article title

Analyst Ratings Changes

Several research analysts recently issued reports on the stock. BMO Capital Markets upped their target price on shares of Procter & Gamble from $169.00 to $170.00 and gave the stock an “outperform” rating in a research report on Monday, June 29th. JPMorgan Chase & Co. lowered their price target on Procter & Gamble from $164.00 to $162.00 and set an “overweight” rating on the stock in a research report on Thursday. Rothschild & Co Redburn dropped their price target on Procter & Gamble from $157.00 to $155.00 and set a “neutral” rating for the company in a research note on Monday, April 27th. Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $163.00 price objective on shares of Procter & Gamble in a report on Monday, April 27th. Finally, Barclays reduced their price objective on Procter & Gamble from $155.00 to $146.00 and set an “equal weight” rating on the stock in a research report on Tuesday, April 14th. Twelve investment analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $161.42.

View Our Latest Stock Analysis on PG

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.

Read More

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.